<DOC>
	<DOCNO>NCT00035074</DOCNO>
	<brief_summary>Patients inflammatory bowel disease ( IBD ) require methotrexate ( MTX ) treatment currently receive drug injection . MTX also available pill give mouth know well drug enters body patient Crohn 's disease ulcerative colitis . This study do compare much MTX enters body drug take mouth compare give injection . If drug well absorbed , may allow patient receive drug mouth .</brief_summary>
	<brief_title>A Pharmacokinetic Study Determine Oral Bioavailability Methotrexate Patients With Inflammatory Bowel Disease</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Adult pediatric patient IBD ( CD UC ) currently receive MTX part clinical care . Patients must receive weekly MTX dose 7.5 40 mg/m2 . Weight &gt; = 12 kg . Normal serum creatinine .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
</DOC>